In conclusion, our study corroborates a previous observation from a study in Scotland that p53 mutant tumors are more common in breast cancer patients from low income, socially deprived communities than in patients from high SES communities, indicating that lifetime exposures associated with a woman’s SES may impact breast tumor biology. This evidence concerns the gene TP53 and breast cancer.